Amber Blair, PA
Physician Assistant · Charlotte, NCNPI 1366782781
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 25.7% of the total. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,259 payments — averaging $437.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$141K
- Johnson & Johnson$80K
- LEO Pharma Inc.$77K
- Arcutis Biotherapeutics, Inc.$59K
- Sun Pharmaceutical Industries Inc.$49K
- Lilly USA, LLC$36K
- plus $109K from 29 others
What the payments were for
- Consulting fees$110,46820%
- Speaking & faculty fees$292,67353%
- Travel & lodging$108,19820%
- Food & beverage$39,1657%
- Education$1940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$550,697 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Unoready PenSecukinumab | 14 | $117,101 |
| Fluorouracil | 71 | $4,867 |
| Clobetasol Propionate | 63 | $2,453 |
| Ketoconazole | 85 | $1,322 |
| Triamcinolone Acetonide | 88 | $987 |
| Doxycycline Hyclate | 55 | $577 |
| Ciclopirox | 19 | $444 |
| Desonide | 12 | $390 |
| ValacyclovirValacyclovir Hcl | 16 | $251 |
| Mupirocin | 20 | $156 |
| Cephalexin | 14 | $137 |
| Finasteride | 11 | $130 |
| Doxycycline Monohydrate | 11 | $117 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Charlotte
- Rachel HolzhauerCharlotte$739K
- Kristin CabedaCharlotte$135K
- Meghan EmigCharlotte$124K
- Juleidy TurnipseedCharlotte$84K
- Erin SiceloffCharlotte$50K
- Ronald RodriguezCharlotte$31K
- Lamiaa TolbaCharlotte$29K
- Sanaya GandhiCharlotte$29K
- Jacqueline LeyrerCharlotte$24K
- Mackenzie McArthurCharlotte$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.